85 results
Page 2 of 5
6-K/A
EX-99.1
b67uu4qn0
1 May 23
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
4:03pm
6-K
EX-99.1
mrx7p5caj7zs t6
16 Dec 22
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
8:06am
POS AM
4hlpo4 sx3jplza4eskr
14 Dec 22
Prospectus update (post-effective amendment)
8:04am
6-K
EX-99.1
12o 97299kbnyh2
30 Nov 22
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
6:15am
424B3
p75 3v3hn4
1 Jul 22
Prospectus supplement
4:10pm
F-1/A
we6j2u
28 Jun 22
Registration statement (foreign) (amended)
4:02pm
F-1/A
mxs1svpp
21 Jun 22
Registration statement (foreign) (amended)
5:07pm
F-1/A
zoe1yaa7zg2y0
10 Jun 22
Registration statement (foreign) (amended)
4:02pm
F-1
9ozld2e1obpv 47zca
27 May 22
Registration statement (foreign)
4:26pm
6-K
EX-99.1
ex863m2bmn0ns9d3u lh
19 May 22
Current report (foreign)
6:27am
425
ypoiz4dv1zcy
11 May 22
Business combination disclosure
9:19pm
425
10r1a
4 May 22
Business combination disclosure
4:03pm
424B3
sl61gx al
4 May 22
Prospectus supplement
4:01pm
425
assbtwc
12 Apr 22
Business combination disclosure
4:15pm
425
zuezy1 h6rzc
12 Apr 22
Business combination disclosure
6:47am
424B3
bjv371cx0q2 9ag8dp7s
11 Apr 22
Prospectus supplement
6:03am
425
ehrhdldmc2kjz0kugz
31 Mar 22
Business combination disclosure
11:51am